nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1B—telencephalic ventricle—bipolar disorder	0.026	0.226	CbGeAlD
Xylometazoline—HTR1D—telencephalic ventricle—bipolar disorder	0.0252	0.219	CbGeAlD
Xylometazoline—Oxymetazoline—HTR2C—bipolar disorder	0.0173	0.611	CrCbGaD
Xylometazoline—Oxymetazoline—HTR2A—bipolar disorder	0.011	0.389	CrCbGaD
Xylometazoline—ADRA2A—blood plasma—bipolar disorder	0.00701	0.0609	CbGeAlD
Xylometazoline—ADRA1B—nervous system—bipolar disorder	0.00488	0.0424	CbGeAlD
Xylometazoline—ADRA1D—nervous system—bipolar disorder	0.00477	0.0415	CbGeAlD
Xylometazoline—ADRA2C—adrenal cortex—bipolar disorder	0.00446	0.0387	CbGeAlD
Xylometazoline—ADRA1B—brain—bipolar disorder	0.00373	0.0324	CbGeAlD
Xylometazoline—HTR1B—nervous system—bipolar disorder	0.00369	0.032	CbGeAlD
Xylometazoline—ADRA1D—brain—bipolar disorder	0.00365	0.0317	CbGeAlD
Xylometazoline—HTR1D—nervous system—bipolar disorder	0.00357	0.031	CbGeAlD
Xylometazoline—HTR1B—brain—bipolar disorder	0.00282	0.0245	CbGeAlD
Xylometazoline—ADRA1A—nervous system—bipolar disorder	0.00274	0.0238	CbGeAlD
Xylometazoline—HTR1D—brain—bipolar disorder	0.00273	0.0237	CbGeAlD
Xylometazoline—ADRA2C—nervous system—bipolar disorder	0.00261	0.0227	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—bipolar disorder	0.00258	0.0224	CbGeAlD
Xylometazoline—ADRA2A—thyroid gland—bipolar disorder	0.00248	0.0215	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—bipolar disorder	0.00246	0.0214	CbGeAlD
Xylometazoline—ADRA1A—brain—bipolar disorder	0.0021	0.0182	CbGeAlD
Xylometazoline—ADRA2A—nervous system—bipolar disorder	0.00209	0.0181	CbGeAlD
Xylometazoline—ADRA2C—brain—bipolar disorder	0.002	0.0174	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—bipolar disorder	0.00196	0.017	CbGeAlD
Xylometazoline—ADRA2A—brain—bipolar disorder	0.00159	0.0138	CbGeAlD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD2—bipolar disorder	0.000171	0.0002	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD1—bipolar disorder	0.000171	0.000199	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2C—bipolar disorder	0.000171	0.000199	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—ADCY2—bipolar disorder	0.00017	0.000199	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—DPYD—bipolar disorder	0.00017	0.000198	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	0.000169	0.000197	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD2—bipolar disorder	0.000168	0.000196	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—ADCY2—bipolar disorder	0.000166	0.000194	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	0.000166	0.000194	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TRPC3—bipolar disorder	0.000166	0.000194	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HTR2A—bipolar disorder	0.000166	0.000194	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR1A—bipolar disorder	0.000165	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD3—bipolar disorder	0.000165	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD2—bipolar disorder	0.000165	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	0.000164	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	0.000164	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	0.000163	0.00019	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TAC1—bipolar disorder	0.000163	0.00019	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—POMC—bipolar disorder	0.000163	0.00019	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HTR2A—bipolar disorder	0.000162	0.00019	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR1A—bipolar disorder	0.000162	0.000189	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	0.000162	0.000189	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD4—bipolar disorder	0.00016	0.000187	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2C—bipolar disorder	0.00016	0.000187	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD1—bipolar disorder	0.00016	0.000187	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TAC1—bipolar disorder	0.00016	0.000186	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	0.000159	0.000185	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	0.000159	0.000185	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADM—bipolar disorder	0.000158	0.000185	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CACNA1C—bipolar disorder	0.000158	0.000184	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2C—bipolar disorder	0.000156	0.000183	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD1—bipolar disorder	0.000156	0.000183	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR2A—bipolar disorder	0.000156	0.000183	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NTRK2—bipolar disorder	0.000155	0.000181	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TRPC3—bipolar disorder	0.000155	0.000181	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD3—bipolar disorder	0.000155	0.000181	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	0.000155	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TSHB—bipolar disorder	0.000154	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PDE4B—bipolar disorder	0.000154	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TACR1—bipolar disorder	0.000154	0.00018	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GSK3A—bipolar disorder	0.000154	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3C2A—bipolar disorder	0.000154	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	0.000154	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	0.000153	0.000179	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TRPC3—bipolar disorder	0.000153	0.000178	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NTRK2—bipolar disorder	0.000152	0.000178	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD3—bipolar disorder	0.000152	0.000177	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	0.000151	0.000177	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	0.000151	0.000176	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GSK3A—bipolar disorder	0.000151	0.000176	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD4—bipolar disorder	0.00015	0.000175	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	0.000149	0.000175	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	0.000149	0.000174	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADM—bipolar disorder	0.000148	0.000173	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD4—bipolar disorder	0.000147	0.000172	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—POMC—bipolar disorder	0.000146	0.00017	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADM—bipolar disorder	0.000146	0.00017	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PDE4B—bipolar disorder	0.000144	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TSHB—bipolar disorder	0.000144	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TACR1—bipolar disorder	0.000144	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CLOCK—bipolar disorder	0.000144	0.000168	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—POMC—bipolar disorder	0.000143	0.000167	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR2A—bipolar disorder	0.000142	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TSHB—bipolar disorder	0.000142	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PDE4B—bipolar disorder	0.000142	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TACR1—bipolar disorder	0.000142	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR1A—bipolar disorder	0.000142	0.000165	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADCY2—bipolar disorder	0.000141	0.000165	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR2A—bipolar disorder	0.000141	0.000165	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TCF7L2—bipolar disorder	0.000141	0.000165	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	0.00014	0.000164	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—TSHB—bipolar disorder	0.00014	0.000164	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—TPH2—bipolar disorder	0.00014	0.000164	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CACNB2—bipolar disorder	0.00014	0.000164	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD2—bipolar disorder	0.00014	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TAC1—bipolar disorder	0.000139	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	0.000139	0.000162	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADCY2—bipolar disorder	0.000138	0.000162	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TCF7L2—bipolar disorder	0.000138	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—SNAP25—bipolar disorder	0.000138	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—DPYD—bipolar disorder	0.000138	0.000161	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD2—bipolar disorder	0.000137	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2C—bipolar disorder	0.000137	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD1—bipolar disorder	0.000137	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	0.000136	0.000158	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NTRK2—bipolar disorder	0.000133	0.000155	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—POMC—bipolar disorder	0.000133	0.000155	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD3—bipolar disorder	0.000132	0.000155	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR2A—bipolar disorder	0.000132	0.000154	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GSK3A—bipolar disorder	0.000132	0.000154	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR2A—bipolar disorder	0.00013	0.000152	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—POMC—bipolar disorder	0.00013	0.000152	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADM—bipolar disorder	0.000129	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD4—bipolar disorder	0.000129	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR2A—bipolar disorder	0.000128	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CACNA1C—bipolar disorder	0.000128	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR1A—bipolar disorder	0.000128	0.000149	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NTRK1—bipolar disorder	0.000127	0.000148	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	0.000126	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	0.000126	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	0.000126	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	0.000126	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TAC1—bipolar disorder	0.000126	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	0.000125	0.000146	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—POMC—bipolar disorder	0.000125	0.000146	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NTRK1—bipolar disorder	0.000124	0.000145	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2C—bipolar disorder	0.000123	0.000144	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD1—bipolar disorder	0.000123	0.000144	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—S100B—bipolar disorder	0.000123	0.000144	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ADCY2—bipolar disorder	0.000122	0.000143	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADCY2—bipolar disorder	0.000121	0.000141	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TCF7L2—bipolar disorder	0.000121	0.000141	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—S100B—bipolar disorder	0.000121	0.000141	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADM—bipolar disorder	0.00012	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NTRK2—bipolar disorder	0.00012	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD2—bipolar disorder	0.00012	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR2A—bipolar disorder	0.00012	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD3—bipolar disorder	0.00012	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR1A—bipolar disorder	0.000119	0.000139	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GSK3A—bipolar disorder	0.000119	0.000139	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR2A—bipolar disorder	0.000118	0.000138	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TAC1—bipolar disorder	0.000118	0.000137	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR1A—bipolar disorder	0.000118	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	0.000117	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	0.000117	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	0.000117	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD4—bipolar disorder	0.000116	0.000136	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	0.000116	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2C—bipolar disorder	0.000115	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD1—bipolar disorder	0.000115	0.000135	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	0.000115	0.000135	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	0.000114	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	0.000114	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—POMC—bipolar disorder	0.000113	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—POMC—bipolar disorder	0.000113	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NTRK2—bipolar disorder	0.000112	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—SNAP25—bipolar disorder	0.000112	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD3—bipolar disorder	0.000112	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GSK3A—bipolar disorder	0.000111	0.00013	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	0.00011	0.000129	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	0.00011	0.000128	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	0.000109	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADCY2—bipolar disorder	0.000109	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TCF7L2—bipolar disorder	0.000109	0.000127	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NRG1—bipolar disorder	0.000109	0.000127	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NTRK1—bipolar disorder	0.000108	0.000127	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD4—bipolar disorder	0.000108	0.000127	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD2—bipolar disorder	0.000108	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	0.000107	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	0.000107	0.000125	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NRG1—bipolar disorder	0.000106	0.000124	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—S100B—bipolar disorder	0.000105	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—POMC—bipolar disorder	0.000105	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	0.000105	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—COMT—bipolar disorder	0.000105	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	0.000104	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MAOA—bipolar disorder	0.000104	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	0.000104	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	0.000103	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—POMC—bipolar disorder	0.000102	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADCY2—bipolar disorder	0.000102	0.000119	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TCF7L2—bipolar disorder	0.000102	0.000119	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD2—bipolar disorder	0.000101	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	0.000101	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	0.000101	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	0.0001	0.000117	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	0.0001	0.000117	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	9.94e-05	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ADCY2—bipolar disorder	9.92e-05	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	9.81e-05	0.000115	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2A—bipolar disorder	9.8e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NTRK1—bipolar disorder	9.79e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	9.76e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	9.73e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	9.72e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	9.7e-05	0.000113	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	9.6e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—POMC—bipolar disorder	9.57e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	9.55e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—S100B—bipolar disorder	9.52e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	9.48e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	9.41e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	9.37e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	9.37e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	9.3e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	9.21e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	9.15e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	9.11e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	9.07e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	9.03e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	9e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	8.92e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	8.89e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—S100B—bipolar disorder	8.89e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	8.83e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	8.81e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—S100B—bipolar disorder	8.75e-05	0.000102	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	8.56e-05	9.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—COMT—bipolar disorder	8.49e-05	9.91e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MTHFR—bipolar disorder	8.45e-05	9.87e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MAOA—bipolar disorder	8.43e-05	9.84e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NRG1—bipolar disorder	8.4e-05	9.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	8.39e-05	9.8e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	8.36e-05	9.76e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	8.29e-05	9.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	8.26e-05	9.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	8.21e-05	9.58e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	8e-05	9.34e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GSK3B—bipolar disorder	7.89e-05	9.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	7.85e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—POMC—bipolar disorder	7.83e-05	9.14e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—INS—bipolar disorder	7.79e-05	9.09e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—S100B—bipolar disorder	7.77e-05	9.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	7.77e-05	9.07e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	7.73e-05	9.02e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	7.72e-05	9.02e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—POMC—bipolar disorder	7.67e-05	8.95e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—INS—bipolar disorder	7.62e-05	8.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—bipolar disorder	7.57e-05	8.84e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	7.43e-05	8.67e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—S100B—bipolar disorder	7.22e-05	8.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	7.08e-05	8.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	6.96e-05	8.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MTHFR—bipolar disorder	6.86e-05	8.01e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	6.86e-05	8.01e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—POMC—bipolar disorder	6.76e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	6.75e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—INS—bipolar disorder	6.72e-05	7.85e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—POMC—bipolar disorder	6.7e-05	7.82e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—INS—bipolar disorder	6.66e-05	7.78e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	6.37e-05	7.44e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	6.19e-05	7.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GSK3B—bipolar disorder	6.1e-05	7.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—POMC—bipolar disorder	6.05e-05	7.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—INS—bipolar disorder	6.02e-05	7.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	5.75e-05	6.71e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	5.7e-05	6.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—POMC—bipolar disorder	5.65e-05	6.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—INS—bipolar disorder	5.62e-05	6.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	5.61e-05	6.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—POMC—bipolar disorder	5.56e-05	6.49e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—INS—bipolar disorder	5.53e-05	6.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—POMC—bipolar disorder	5.49e-05	6.41e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—INS—bipolar disorder	5.46e-05	6.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	4.98e-05	5.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—POMC—bipolar disorder	4.94e-05	5.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—INS—bipolar disorder	4.91e-05	5.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	4.63e-05	5.4e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—POMC—bipolar disorder	4.59e-05	5.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—INS—bipolar disorder	4.56e-05	5.33e-05	CbGpPWpGaD
